Precision BioSciences Inc. (DTIL): Long-Term Debt to Capital Ratio

Reliable bioreactor delivery ensures the research precision of Precision BioSciences (DTIL). The trajectory of the long-term debt-to-equity ratio on the GURU.Markets chart confirms stability, with the value fixed at 0.54. The ARCUS platform patents create financial inertia through licensing, while strict control over hazardous material disposal minimizes the laboratories' environmental footprint.

Amid market uncertainty, capital preservation through debt load analysis becomes the investor's priority. This ratio correlates liabilities with maturities exceeding one year against total capital to determine the business's financial autonomy. By analyzing the long-term debt structure relative to equity, one can assess the risk of credit shocks. For Precision BioSciences (DTIL), minimizing borrowings is critical during the transition to an ultra-lean model. The company's stability now depends exclusively on partner royalties rather than financial leverage.